Sporotrichosis is a chronic pyogranulomatous infection caused by the thermally dimorphic fungus Sporothrix schenckii. Infection is usually limited to the skin and subcutaneous tissues, but can involve virtually any organ in its disseminated form. Less common localized forms of sporotrichosis include arthritis, osteomyelitis, meningitis, chronic pneumonitis, and laryngeal and ocular disease.


Central Nervous System Disease Cutaneous Leishmaniasis Sphagnum Moss Direct Inoculation Hematogenous Dissemination 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Schenck BR. Refractory subcutaneous abscesses caused by a ­fungus possibly related to the sporotricha. Johns Hopkins Hosp Bull. 1898;9:286–90.Google Scholar
  2. 2.
    Hektoen L, Perkins CF. Refractory subcutaneous abscesses caused by Sporothrix schenckii. A new pathogenic fungus. J Exp Med. 1900;5:77–89.PubMedCrossRefGoogle Scholar
  3. 3.
    Carmichael JW. Chrysosporium and some other aleuriosporic hyphomycetes. Can J Bot. 1962;40:1137–73.CrossRefGoogle Scholar
  4. 4.
    de Beurmann L, Gougerot H. Les Sporotrichoses. Paris: Felix Alcan; 1912.Google Scholar
  5. 5.
    Transvaal Mine Medical Officers’ Association. Sporotrichosis infection in mines of the Witwatersrand: a symposium. Johannesburg, Transvaal Chamber of Mines, 1947.Google Scholar
  6. 6.
    Ellner PD. An outbreak of sporotrichosis in Florida. JAMA. 1960;173:113–7.Google Scholar
  7. 7.
    D’Alessio DJ, Leavens LJ, Strumpf GB, Smith CD. An outbreak of sporotrichosis in Vermont associated with sphagnum moss as the source of infection. N Engl J Med. 1965;272:1054–8.CrossRefGoogle Scholar
  8. 8.
    Powell KE, Taylor A, Phillips BJ, et al. Cutaneous sporotrichosis in forestry workers: epidemic due to contaminated sphagnum moss. JAMA. 1978;240:232–5.PubMedCrossRefGoogle Scholar
  9. 9.
    Itoh M, Okamoto S, Kariya H. Survey of 200 cases of sporotrichosis. Dermatologica. 1986;172:209–13.PubMedCrossRefGoogle Scholar
  10. 10.
    Centers for Disease Control. Multistate outbreak of sporotrichosis in seedling handlers. MMWR. 1988;37:652–3.Google Scholar
  11. 11.
    Kushuhara M, Hachisuka H, Sasai Yoichiro. Statistical survey of 150 cases with sporotrichosis. Mycopathologia. 1988;102:129–33.CrossRefGoogle Scholar
  12. 12.
    Kwon-Chung KJ, Bennett JE. Sporotrichosis. In: Kwon-Chung KJ, Bennett JE, editors. Medical Mycology. Philadelphia: Lea & Febiger; 707. p. 729–1992.Google Scholar
  13. 13.
    Barile F, Mastrolonardo M, Loconsole F, Rantuccio F. Cutaneous sporotrichosis in the period 1978–1992 in the province of Bari, Apulia, Southern Italy. Mycoses. 1993;36:182–5.Google Scholar
  14. 14.
    Hajjeh R, McDonnell S, Reef S, et al. Outbreak of sporotrichosis among tree nursery workers. J Infect Dis. 1997;176:499–504.PubMedCrossRefGoogle Scholar
  15. 15.
    Barros MB, Schubach AO, Schubach TM, Wanke B, Lambert-Passos SR. An epidemic of sporotrichosis in Rio de Janeiro, Brazil: epidemiological aspects of a series of cases. Epidemiol Infect. 2008;136:1192–6.PubMedCrossRefGoogle Scholar
  16. 16.
    da Rosa AC, Scroferneker ML, Vettorato R, Gervini RL, Vettorato G, Weber A. Epidemiology of sporotrichosis: a study of 304 cases in Brazil. J Am Acad Dermatol. 2005;52:451–9.PubMedCrossRefGoogle Scholar
  17. 17.
    Agarwal S, Gopal K, Umesh Kumar B. Sporotrichosis in Uttarakhand (India): a report of nine cases. Int J Dermatol. 2008;47:367–71.PubMedCrossRefGoogle Scholar
  18. 18.
    de Meyer EM, de Beer ZW, Summerbell RC, et al. Taxonomy and phylogeny of new wood-and soil-inhabiling Sporothrix species in the Ophiostoma stenoceras-Sporothrix schenckii complex. Mycologia. 2008;100:647–61.PubMedCrossRefGoogle Scholar
  19. 19.
    Marimon R, Gené J, Cano J, Trilles L, Lazéra M, Guarro J. Molecular phylogeny of Sporothrix schenckii. J Clin Microbiol. 2006;44:3251–6.PubMedCrossRefGoogle Scholar
  20. 20.
    Marimon R, Cano J, Gené J, Sutton D, Kawasaki M, Guarro J. Sporothrix brasiliensis, S. globosa, and S. mexicana, three new Sporothrix species of clinical interest. J Clin Microbiol. 2007;45:3198–206.PubMedCrossRefGoogle Scholar
  21. 21.
    Marimon R, Gené J, Cano J, Guarro J. Sporothrix luriei: a rare fungus from clinical origin. Med Mycol. 2008;46:621–5.PubMedCrossRefGoogle Scholar
  22. 22.
    Alberici F, Paties CT, Lombardi G, Ajello L, Daufman L, Chandler F. Sporothrix schenckii var luriei as the cause of sporotrichosis in Italy. Eur J Epidemiol. 1989;5:173–7.PubMedCrossRefGoogle Scholar
  23. 23.
    Mackinnon JE, Conti-Diaz IA, Yarzabal LA. Experimental sporotrichosis, ambient temperature and amphotericin B. Sabouraudia. 1964;3:192–4.PubMedGoogle Scholar
  24. 24.
    Dixon DM, Duncan RA, Hurn NJ. Use of a mouse model to evaluate clinical and environmental isolates of Sporothrix spp. from the largest U.S. outbreak of sporotrichosis. J Clin Microbiol. 1992;30:951–4.PubMedGoogle Scholar
  25. 25.
    Tachibani T, Matsuyama T, Ito M, Mitsuyama M. Sporothrix schenckii thermo-intolerant mutants losing fatal visceral infectivity but retaining high cutaneous infectivity. Med Mycol. 2001;39:295–8.Google Scholar
  26. 26.
    Romero-Martinez R, Wheeler M, Guerreo-Plata A, Rico G, Torres-Guerrero H. Biosynthesis and functions of melanin in Sporothrix schenckii. Infect Immun. 2000;68:3696–703.PubMedCrossRefGoogle Scholar
  27. 27.
    Kauffman CA. Sporotrichosis. Clin Infect Dis. 1999;29:231–7.PubMedCrossRefGoogle Scholar
  28. 28.
    Fernandes KS, Mathews HL, Lopes Bezerra LM. Differences in virulence of Sporothrix schenckii conidia related to culture conditions and cell-wall components. J Med Microbiol. 1999;48:195–203.PubMedCrossRefGoogle Scholar
  29. 29.
    Mackinnon JE, Conti-Diaz IA. The effect of temperature on sporotrichosis. Sabouraudia. 1962;2:56–9.Google Scholar
  30. 30.
    Mackinnon JE, Conti-Diaz IA, Gezuele E, Civila E, DaLuz S. Isolation of Sporothrix schenckii from nature and considerations on its pathogenicity and ecology. Sabouraudia. 1969;7:38–45.PubMedGoogle Scholar
  31. 31.
    Arenas R, Miller D, Campos-Macias P. Epidemiological data and molecular characterization (mtDNA) of Sporothrix schenckii in 13 cases from Mexico. Int J Dermatol. 2007;46:177–9.PubMedGoogle Scholar
  32. 32.
    Mesa-Arango AC, Reyes-Montes M, Pérez-Mejía A, et al. Phenotyping and genotyping of Sporothrix schenckii isolates according to geographic origin and clinical form of sporotrichosis. J Clin Microbiol. 2002;40:3004–11.PubMedCrossRefGoogle Scholar
  33. 33.
    Ochoa AG, Ricoy E, Velasco O, Lopez R, Navarrete F. Valoracion comparativa de los antigenos polisacarido y cellar de Sporothrix schenckii. Rev Invest Salud Publ Mex. 1970;30:303–15.Google Scholar
  34. 34.
    Velasco-Castrejón O, Gonzalez-Ochoa YA. La esporotricosis en un peque o poblado de la Sierra de Puebla. Rev Invest Salud Publ Mex. 1976;36:133–7.Google Scholar
  35. 35.
    Pappas PG, Tellez I, Deep AA, Nolasco D, Holgado W, Bustamante B. Sporotrichosis in Peru: description of a hyperendemic area. Clin Infect Dis. 2000;30:65–70.PubMedCrossRefGoogle Scholar
  36. 36.
    Centers for Disease Control. Sporotrichosis associated with Wisconsin sphagnum moss. MMWR. 1982;31:542–4.Google Scholar
  37. 37.
    Coles FB, Schuchat A, Hibbs JR, et al. A multistate outbreak of sporotrichosis associated with sphagnum moss. Am J Epidemiol. 1992;136:475–87.PubMedGoogle Scholar
  38. 38.
    Lyon GM, Zurita S, Casquero J, et al. Population-based surveillance and a case-control study of risk factors for endemic lymphocutaneous sporotrichosis in Peru. Clin Infect Dis. 2003;36:34–9.PubMedCrossRefGoogle Scholar
  39. 39.
    Barros MB, Costa KL, Schubach TM, et al. Endemic of zoonotic sporotrichosis: profile of cases in children. Pediatr Infect Dis J. 2008;27:246–50.PubMedCrossRefGoogle Scholar
  40. 40.
    Bonifaz A, Saúl A, Paredes-Solis V, Fierro L, Rosales A, Palacios C, et al. Sporotrichosis in childhood: clinical and therapeutic experience in 25 patients. Pediatr Dermatol. 2007;24:369–72.PubMedCrossRefGoogle Scholar
  41. 41.
    Pluss JL, Opal SM. Pulmonary sporotrichosis: review of treatment and outcome. Medicine (Baltimore). 1986;65:143–53.Google Scholar
  42. 42.
    Carvalho J, Caldwell JB, Radford BL, Feldman AR. Feline-transmitted sporotrichosis in the Southwestern United States. West J Med. 1991;154:462–5.Google Scholar
  43. 43.
    de Lima Barros MB, Schubach TM, Galhardo MC, et al. Sporotrichosis: an emergent zoonosis in Rio de Janeiro. Mem Inst Oswaldo Cruz. 2001;96:777–9.PubMedGoogle Scholar
  44. 44.
    Fleury RN, Taborda PR, Gupta AK, et al. Zoonotic sporotrichosis. Transmission to humans by infected domestic cat scratching: report of four cases in Sao Paulo, Brazil. Int J Dermatol. 2001;40:318.PubMedGoogle Scholar
  45. 45.
    Reed KD, Moore FM, Geiger GE, Stemper ME. Zoonotic transmission of sporotrichosis: case report and review. Clin Infect Dis. 1993;16:384–7.PubMedGoogle Scholar
  46. 46.
    Saravanakumar PS, Eslami P, Zar FA. Lymphocutaneous sporotrichosis associated with a squirrel bite: case report and review. Clin Infect Dis. 1996;23:647–8.PubMedGoogle Scholar
  47. 47.
    de Lima Barros MB, de Oliveira Schubach A, Galhardo MC, Schubach TM, do Valle AC. Sporotrichosis with widespread cutaneous lesions: report of 24 cases related to transmission by domestic cats in Rio de Janeiro, Brazil. Int J Dermatol. 2003;42:677–81.PubMedCrossRefGoogle Scholar
  48. 48.
    Haddad VJ, Miot HA, Bartoli LD, Cardoso AC, de Camargo RM. Localized lymphatic sporotrichosis after fish-induced injury. Med Mycol. 2002;40:425–7.PubMedCrossRefGoogle Scholar
  49. 49.
    Schubach A, de Lima Barros M, Wanke B. Epidemic sporotrichosis. Curr Opin Infect Dis. 2008;21:129–33.PubMedCrossRefGoogle Scholar
  50. 50.
    Kovarik CL, Neyra E, Bustamante B. Evaluation of cats as the source of endemic sporotrichosis in Peru. Med Mycol. 2008;46:53–6.PubMedCrossRefGoogle Scholar
  51. 51.
    Thompson DW, Kaplan AW. Laboratory-acquired sporotrichosis. Sabouraudia. 1977;15:167–70.PubMedGoogle Scholar
  52. 52.
    Cooper DR, Dixon DM, Salkin IF. Laboratory-acquired sporotrichosis. J Med Vet Mycol. 1992;30:169–91.PubMedCrossRefGoogle Scholar
  53. 53.
    Garrett HD, Robbins JB. An unusual occurrence of sporotrichosis: eight cases in one residence. Arch Dermatol. 1960;82:570–1.PubMedGoogle Scholar
  54. 54.
    Yamada Y, Dekio S, Jidoi J, Ozasa S, Tohgi K. A familial occurrence of sporotrichosis. J Dermatol. 1990;17:255–9.PubMedGoogle Scholar
  55. 55.
    Umemoto N, Demitsu T, Osawa M, Toda A, Kawasaki M, Mochizuki T. Sporotrichosis in a husband and wife. J Dermatol. 2005;32:569–73.PubMedGoogle Scholar
  56. 56.
    Forrester HR. Sporotrichosis, an occupational dermatosis. JAMA. 1926;87:1605–9.Google Scholar
  57. 57.
    Rathi SK, Raman M, Rajendran C. Localized cutaneous sporotrichosis lasting for 10 years. Indian J Dermatol Venereol Leprol. 2003;69:239–40.PubMedGoogle Scholar
  58. 58.
    Ware AJ, Cockrell CJ, Skiest DJ, Kussman HM. Disseminated sporotrichosis with extensive cutaneous involvement in a patient with AIDS. J Am Acad Dermatol. 1999;40:350–5.PubMedCrossRefGoogle Scholar
  59. 59.
    Carvalho MTM, de Castro AP, Baby C, Werner B, Neto JF, Queiroz-Telles F. Disseminated cutaneous sporotrichosis in a patient with AIDS: report of a case. Rev Soc Bras Med Trop. 2002;35:655–9.PubMedGoogle Scholar
  60. 60.
    Yelverton CB, Stetson CL, Bang RH, Clark JW, Butler DF. Fatal sporotrichosis. Cutis. 2006;78:253–6.PubMedGoogle Scholar
  61. 61.
    Hardman S, Stephenson I, Jenkins DR, Wiselka MJ, Johnson EM. Disseminated Sporothrix schenckii in a patient with AIDS. J Infect. 2005;51:e73–7.PubMedCrossRefGoogle Scholar
  62. 62.
    Altner PC, Turner RR. Sporotrichosis of bones and joints: review of the literature and report of six cases. Clin Orthop. 1970;68:138–48.PubMedGoogle Scholar
  63. 63.
    Crout JE, Brewer NS, Tompkins RB. Sporotrichosis arthritis: clinical features in seven patients. Ann Intern Med. 1977;86:294–7.PubMedGoogle Scholar
  64. 64.
    Chowdhary G, Weinstein A, Klein R, Mascarenhas BR. Sporotrichal arthritis. Ann Rheum Dis. 1991;50:112–4.PubMedCrossRefGoogle Scholar
  65. 65.
    Yao J, Penn RG, Ray S. Articular sporotrichosis. Clin Orthop. 1986;204:207–14.PubMedGoogle Scholar
  66. 66.
    Appenzeller S, Amaral TN, Amstalden EMI, et al. Sporothrix schenckii infection presented as monoarthritis: report of two cases and review of the literature. Clin Rheumatol. 2006;25:926–8.PubMedCrossRefGoogle Scholar
  67. 67.
    Wilson DE, Mann J, Bennett JE, Utz JP. Clinical features of extracutaneous sporotrichosis. Medicine (Baltimore). 1967;46:265–79.CrossRefGoogle Scholar
  68. 68.
    Stratton CW, Lichtenstein KA, Lowenstein SR, Phelps DB, Reller LB. Granulomatous tenosynovitis and carpal tunnel syndrome caused by Sporothrix schenckii. Am J Med. 1981;71:161–4.PubMedCrossRefGoogle Scholar
  69. 69.
    Schwartz DA. Sporothrix tenosynovitis – differential diagnosis of granulomatous inflammatory disease of the joints. J Rheumatol. 1989;16:550–3.PubMedGoogle Scholar
  70. 70.
    Henry LR, Danaher PJ, Boseley ME. Laryngeal sporotrichosis mimicking merkel cell carcinoma recurrence. Otolaryngol Head Neck Surg. 2005;132:336–8.PubMedCrossRefGoogle Scholar
  71. 71.
    Khabie N, Boyce TG, Roberts GD, Thompson DM. Laryngeal sporotrichosis causing stridor in a young child. Int J Pediatr Otorhinolaryngol. 2003;67:819–23.PubMedCrossRefGoogle Scholar
  72. 72.
    Torrealba JR, Carvalho J, Corliss R, England D. Laryngeal granulomatous infection by Sporothrix schenckii. Otolaryngol Head Neck Surg. 2005;132:339–40.PubMedCrossRefGoogle Scholar
  73. 73.
    Lurie HI. Five unusual cases of sporotrichosis from South Africa showing lesions in muscles, bones, and viscera. Br J Surg. 1963;50:585–91.PubMedCrossRefGoogle Scholar
  74. 74.
    Castrejon OV, Robles M, Zubieta Arroyo OE. Fatal fungaemia due to Sporothrix schenckii. Mycoses. 1995;38:373–6.PubMedCrossRefGoogle Scholar
  75. 75.
    Donabedian H, O’Donnell E, Olszewski C, MacArthur RD, Budd N. Disseminated cutaneous and meningeal sporotrichosis in an AIDS patient. Diagn Microbiol Infect Dis. 1994;18:111–5.PubMedCrossRefGoogle Scholar
  76. 76.
    Edwards C, Reuther WL, Greer DL. Disseminated osteoarticular sporotrichosis: treatment in a patient with acquired immunodeficiency syndrome. South Med J. 2000;93:803–6.PubMedGoogle Scholar
  77. 77.
    Cartwright MJ, Promersberger M, Stevens GA. Sporothrix schenckii endophthalmitis presenting as granulomatous uveitis. Br J Ophthalmol. 1993;77:61–2.PubMedCrossRefGoogle Scholar
  78. 78.
    Kurosawa A, Pollock SC, Collins MP, Kraff CR, Tso MO. Sporothrix schenckii endophthalmitis in a patient with human immunodeficiency virus infection. Arch Ophthalmol. 1988;106:376–80.PubMedGoogle Scholar
  79. 79.
    Burch JM, Morelli JG, Weston WL. Unsuspected sporotrichosis in childhood. Pediatr Infect Dis J. 2001;20:442–5.PubMedCrossRefGoogle Scholar
  80. 80.
    Chandler JW, Kriel RL, Tosh FE. Childhood sporotrichosis. Am J Dis Child. 1968;115:368–72.PubMedGoogle Scholar
  81. 81.
    Gluckman I. Sporotrichosis in children. S Afr Med J. 1965;39:991–1002.PubMedGoogle Scholar
  82. 82.
    Orr ER, Riley HD. Sporotrichosis in childhood: report of ten cases. J Pediatr. 1971;78:951–7.PubMedCrossRefGoogle Scholar
  83. 83.
    al-Tawfiq JA, Wools KK. Disseminated sporotrichosis and Sporothrix schenckii fungemia as the initial presentation of human immunodeficiency virus infection. Clin Infect Dis. 1998;26:1403–6.PubMedCrossRefGoogle Scholar
  84. 84.
    Fontes PC, Kitakawa D, Carvalho YR, Brandão AA, Cabral LA, Almeida JD. Sporotrichosis in an HIV-positive man with oral lesions: a case report. Acta Cytol. 2007;51:648–50.PubMedGoogle Scholar
  85. 85.
    Fonseca-Reyes S, Maldonado F, Miranda-Ackerman R, et al. Extracutaneous sporotrichosis in a patient with liver cirrhosis. Rev Iberoam Micol. 2007;24:41–3.PubMedCrossRefGoogle Scholar
  86. 86.
    Keiser P, Whittle D. Sporotrichosis in human immunodeficiency virus-infected patients: report of a case. Rev Infect Dis. 1991;13:1027–8.PubMedGoogle Scholar
  87. 87.
    Silva-Vergara ML, Maneira FR, De Oliveira RM, Santos CT, Etchebehere RM, Adad SJ. Multifocal sporotrichosis with meningial involvement in a patient with AIDS. Med Mycol. 2005;43:187–90.PubMedCrossRefGoogle Scholar
  88. 88.
    Vilela R, Souza GF, Cota GF, Mendoza L. Cutaneous and meningeal sporotrichosis in a HIV patient. Rev Iberoam Micol. 2007;24:161–3.PubMedCrossRefGoogle Scholar
  89. 89.
    Kostman JR, DiNubile MJ. Nodular lymphangitis: a distinctive but often unrecognized syndrome. Ann Intern Med. 1993;118:883–8.PubMedGoogle Scholar
  90. 90.
    Farley ML, Fagan MF, Mabry LC, Wallace RJ. Presentation of Sporothrix schenckii in pulmonary cytology specimens. Acta Cytol. 1991;35:389–95.PubMedGoogle Scholar
  91. 91.
    Scott EN, Kaufman L, Brown AC, Muchmore HG. Serologic studies in the diagnosis and management of meningitis due to Sporothrix schenckii. N Engl J Med. 1987;317:935–8.PubMedCrossRefGoogle Scholar
  92. 92.
    Almeida-Paes R, Pimenta MA, Monteiro PC, Nosanchuk JD, Zancopé-Oliveira RM. Immunoglobulins G, M, and A against Sporothrix schenckii exoantigens in patients with sporotrichosis before and during treatment with itraconazole. Clin Vaccine Immunol. 2007;14:1149–57.PubMedCrossRefGoogle Scholar
  93. 93.
    Bernardes-Engemann AR, Costa RC, Miguens BR, et al. Development of an enzyme-linked immunosorbent assay for the serodiagnosis of several clinical forms of sporotrichosis. Med Mycol. 2005;43:487–93.PubMedCrossRefGoogle Scholar
  94. 94.
    Costa RO, de Mesquita KC, Damasco PS, et al. Infectious arthritis as the single manifestation of sporotrichosis: serology from serum and synovial fluid samples as an aid to diagnosis. Rev Iberoam Micol. 2008;25:54–6.PubMedCrossRefGoogle Scholar
  95. 95.
    Kauffman CA, Bustamante B, Chapman SW, Pappas PG. Clinical practice guidelines for the management of sporotrichosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis. 2007;45:1255–65.PubMedCrossRefGoogle Scholar
  96. 96.
    de Almeida HL, Lettnin CB, Barbosa JL, Dias MC. Spontaneous resolution of zoonotic sporotrichosis during pregnancy. Rev Inst Med Trop S Paulo. 2009;51:237–8.PubMedGoogle Scholar
  97. 97.
    Urabe H, Nagasthima T. Mechanism of antifungal action of potassium iodide on sporotrichosis. Dermatol Int. 1969;1:36–8.CrossRefGoogle Scholar
  98. 98.
    Sterling JB, Heymann WR. Potassium iodide in dermatology: a 19th century drug for the 21st century-users, pharmacology, adverse effects, and contraindications. J Am Acad Dermatol. 2000;43:691–7.PubMedCrossRefGoogle Scholar
  99. 99.
    Kauffman CA. Old and new therapies for sporotrichosis. Clin Infect Dis. 1995;21:981–5.PubMedGoogle Scholar
  100. 100.
    Rex JH, Bennett JE. Administration of potassium iodide to normal volunteers does not increase killing of Sporothrix schenckii by their neutrophils or monocytes. J Med Vet Mycol. 1990;28:158–89.CrossRefGoogle Scholar
  101. 101.
    Cabezas C, Bustamante B, Holgado W, Begue RE. Treatment of cutaneous sporotrichosis with one daily dose of potassium iodide. Pediatr Infect Dis J. 1996;15:352–4.PubMedCrossRefGoogle Scholar
  102. 102.
    Coskun B, Saral Y, Akpolat N, Ataseven A, Çiçek D. Sporotrichosis successfully treated with terbinafine and potassium iodide: Case report and review of the literature. Mycopathologia. 2004;158:53–6.PubMedCrossRefGoogle Scholar
  103. 103.
    Thomas CL, Pierce HE, Babiner GW. Sporotrichosis responding to fever therapy. JAMA. 1951;147:1342–3.Google Scholar
  104. 104.
    Hiruma M, Kagawa S. The effects of heat on Sporothrix schenckii in vitro and in vivo. Mycopathologica. 1983;84:21–30.CrossRefGoogle Scholar
  105. 105.
    Hiruma M, Kawada A, Noguchi H, Ishibashi A, Conti Diaz IA. Hyperthermic treatment of sporotrichosis: experimental use of infrared and far infrared rays. Mycoses. 1992;35:293–9.PubMedCrossRefGoogle Scholar
  106. 106.
    Sharkey-Mathis PK, Kauffman CA, Graybill JR, et al. Treatment of sporotrichosis with itraconazole. Am J Med. 1993;95:279–85.PubMedCrossRefGoogle Scholar
  107. 107.
    Restrepo A, Robledo J, Gomez I, Tabares AM, Gutiérrez R. Itraconazole therapy in lymphangitic and cutaneous sporotrichosis. Arch Dermatol. 1986;122:413–7.PubMedCrossRefGoogle Scholar
  108. 108.
    Bonifaz A, Fierro L, Saúl A, Ponce RM. Cutaneous sporotrichosis. Intermittent treatment (pulses) with itraconazole. Eur J Dermatol. 2008;18:61–4.PubMedGoogle Scholar
  109. 109.
    Kauffman CA, Pappas PG, McKinsey DS, et al. Treatment of lymphocutaneous and visceral sporotrichosis with fluconazole. Clin Infect Dis. 1996;22:46–50.PubMedGoogle Scholar
  110. 110.
    Calhoun DL, Waskin H, White MP, et al. Treatment of systemic sporotrichosis with ketoconazole. Rev Infect Dis. 1991;13:47–51.PubMedGoogle Scholar
  111. 111.
    Alvarado-Ramírez E, Torrez-Rodríguez JM. In vitro susceptibility of Sporothrix schenckii to six antifungal agents determined using three differrent methods. Antimicrob Agents Chemother. 2007;51:2420–3.PubMedCrossRefGoogle Scholar
  112. 112.
    Marimon R, Serena C, Gené J, Cano J, Guarro J. In vitro antifungal susceptibilities of five species of Sporothrix. Antimicrob Agents Chemother. 2008;2:732–4.CrossRefGoogle Scholar
  113. 113.
    Hull PR, Vismer HF. Treatment of cutaneous sporotrichosis with terbinafine. Br J Dermatol. 1992;39:51–5.CrossRefGoogle Scholar
  114. 114.
    Hull PR, Vismer HF. Potential use of terbinafine in the treatment of cutaneous sporotrichosis. Rev Contemp Pharmacother. 1997;8:343–7.Google Scholar
  115. 115.
    Kohler LM, Monteiro PC, Hahn RC, Hamdan JS. In vitro susceptibilities of isolates of Sporothrix schenckii to itraconazole and terbinafine. J Clin Microbiol. 2004;42:4319–20.PubMedCrossRefGoogle Scholar
  116. 116.
    Chapman SW, Pappas P, Kauffman C, et al. Comparative evaluation of the efficacy and safety of two doses of terbinafine (500 and 100 mg day(−1)) in the treatment of cutaneous or lymphocutaneous sporotrichosis. Mycoses. 2004;47:62–8.PubMedCrossRefGoogle Scholar
  117. 117.
    Francesconi G, Valle A, Passos S, Reis R, Galhardo M. Terbinafine (250 mg/day): an effective and safe treatment of cutaneous sporotrichosis. J Eur Acad Dermatol Venereol. 2009;23:1273–6.PubMedCrossRefGoogle Scholar
  118. 118.
    Koëter S, Jackson RW. Successful total knee arthroplasty in the presence of sporotrichal arthritis. Knee. 2006;13:236–7.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Division of Infectious, DiseasesUniversity of Alabama at Birmingham School of MedicineBirminghamUSA

Personalised recommendations